167 related articles for article (PubMed ID: 26980833)
1. Features of Circulating Parainfluenza Virus Required for Growth in Human Airway.
Palermo LM; Uppal M; Skrabanek L; Zumbo P; Germer S; Toussaint NC; Rima BK; Huey D; Niewiesk S; Porotto M; Moscona A
mBio; 2016 Mar; 7(2):e00235. PubMed ID: 26980833
[TBL] [Abstract][Full Text] [Related]
2. Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.
Iketani S; Shean RC; Ferren M; Makhsous N; Aquino DB; des Georges A; Rima B; Mathieu C; Porotto M; Moscona A; Greninger AL
mBio; 2018 Jul; 9(4):. PubMed ID: 29970463
[TBL] [Abstract][Full Text] [Related]
3. Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.
Palmer SG; DeVito I; Jenkins SG; Niewiesk S; Porotto M; Moscona A
J Virol; 2014 Nov; 88(22):13495-502. PubMed ID: 25210187
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
[TBL] [Abstract][Full Text] [Related]
5. Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids.
Porotto M; Ferren M; Chen YW; Siu Y; Makhsous N; Rima B; Briese T; Greninger AL; Snoeck HW; Moscona A
mBio; 2019 May; 10(3):. PubMed ID: 31064833
[TBL] [Abstract][Full Text] [Related]
6. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
Palmer SG; Porotto M; Palermo LM; Cunha LF; Greengard O; Moscona A
mBio; 2012; 3(3):. PubMed ID: 22669629
[TBL] [Abstract][Full Text] [Related]
7. Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces.
Marcink TC; Wang T; des Georges A; Porotto M; Moscona A
PLoS Pathog; 2020 Sep; 16(9):e1008883. PubMed ID: 32956394
[TBL] [Abstract][Full Text] [Related]
8. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
9. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease.
Moscona A
J Clin Invest; 2005 Jul; 115(7):1688-98. PubMed ID: 16007245
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.
Jones BG; Hayden RT; Hurwitz JL
Antiviral Res; 2013 Nov; 100(2):562-6. PubMed ID: 24076357
[TBL] [Abstract][Full Text] [Related]
11. Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.
Stone JA; Vemulapati BM; Bradel-Tretheway B; Aguilar HC
J Virol; 2016 Dec; 90(23):10762-10773. PubMed ID: 27654290
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel parainfluenza virus, caviid parainfluenza virus 3, from laboratory guinea pigs (Cavia porcellus).
Simmons JH; Purdy GA; Franklin CL; Trottier P; Churchill AE; Russell RJ; Besch-Williford CL; Riley LK
Comp Med; 2002 Dec; 52(6):548-54. PubMed ID: 12540169
[TBL] [Abstract][Full Text] [Related]
14. Recent developments with live-attenuated recombinant paramyxovirus vaccines.
Le Bayon JC; Lina B; Rosa-Calatrava M; Boivin G
Rev Med Virol; 2013 Jan; 23(1):15-34. PubMed ID: 22570186
[TBL] [Abstract][Full Text] [Related]
15. Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.
Burke CW; Li M; Hurwitz JL; Vogel P; Russell CJ
J Virol; 2015 Apr; 89(7):3568-83. PubMed ID: 25589649
[TBL] [Abstract][Full Text] [Related]
16. Unity in diversity: shared mechanism of entry among paramyxoviruses.
Palgen JL; Jurgens EM; Moscona A; Porotto M; Palermo LM
Prog Mol Biol Transl Sci; 2015; 129():1-32. PubMed ID: 25595799
[TBL] [Abstract][Full Text] [Related]
17. Novel Atlantic bottlenose dolphin parainfluenza virus TtPIV-1 clusters with bovine PIV-3 genotype B strains.
Eberle KC; Neill JD; Venn-Watson SK; McGill JL; Sacco RE
Virus Genes; 2015 Oct; 51(2):198-208. PubMed ID: 26174699
[TBL] [Abstract][Full Text] [Related]
18. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement.
Gui L; Jurgens EM; Ebner JL; Porotto M; Moscona A; Lee KK
mBio; 2015 Feb; 6(1):e02393-14. PubMed ID: 25691596
[TBL] [Abstract][Full Text] [Related]
19. [Interfering and interferonogenic activity of attenuated and original para-influenza viral strains].
Shitikov GS; Boldasov VK
Vopr Virusol; 1977; (4):445-9. PubMed ID: 200011
[TBL] [Abstract][Full Text] [Related]
20. Biology of parainfluenza viruses.
Vainionpää R; Hyypiä T
Clin Microbiol Rev; 1994 Apr; 7(2):265-75. PubMed ID: 8055470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
